Description: Ventripoint Diagnostics Ltd., a medical device company, develops and commercializes diagnostic tools that monitor patients with heart disease primarily in Canada. The company offers Ventripoint Medical System, a medical imaging system that is used to generate three-dimensional models with critical volume and functional measurements of a patient's heart chambers. It also develops a suite of applications for various heart diseases and imaging modalities, including congenital heart disease, pulmonary hypertension and cardiotoxicity in oncology patients. The company is headquartered in Toronto, Canada.
Home Page: www.ventripoint.com
18 Hook Avenue
Toronto,
ON
M6P 1T4
Canada
Phone:
416-848-4156
Officers
| Name | Title |
|---|---|
| Dr. George Adams B.A.Sc., ICD.D., M.A.Sc., Ph.D. | Exec. Chairman & Interim CEO |
| Mr. Victor Hugo C.M.A., CPA | Chief Financial Officer |
| Dr. Alvira Macanovic Ph.D. | VP of Operations, Regulatory Affairs & Quality Assurance |
| Mr. Hirotaka Katagiri | CTO & Bus. Devel. Division Director |
| Ms. Jessica Naman | Director of Marketing |
| Mr. Desmond Hirson | Consultant |
| Mr. Jim Graba | Application Specialist & Chief Trainer |
Exchange: OTCQB
Country: US
Currency: US Dollar ($)
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 8.2705 |
| Price-to-Sales TTM: | 897.0447 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 0 |